A very interesting study used a combination of miR-122 mimic/miR-221 against HCC, which inhibited proliferation, and angiogenesis and reduced the production of cell cycle modulators like cyclin D1 and TGF-β respectively. This evidence concerns the gene TGFB1 and hepatocellular carcinoma.